Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

NIH Scientists Protest Cuts and Call for Restoration of Biomedical Funding

June 10, 2025

More than 1,200 NIH researchers signed the Bethesda Declaration, urging reversal of recent funding cuts and workforce reductions seen as politically motivated. The declaration highlights concerns...

Nanotechnology Innovates Fluid Manipulation with Magnetic Microrobots

June 10, 2025

Scientists at the Chinese Academy of Sciences engineered a magnetic microrobot capable of precise, rapid manipulation of microscopic fluid droplets. This novel device uses a porous, hydrophilic...

Major Funding Granted to Advance Colorectal Cancer Screening Technologies

June 10, 2025

Tagomics secured £860,000 to enhance its colorectal cancer screening platform via collaboration with NHS research entities. Additionally, a comparative study reveals CT colonography outperforms...

Stem Cell-Based Embryo Models Face Regulatory and Ethical Crossroads

June 10, 2025

Advancements in stem cell-derived embryo models (SCBEM) offer unprecedented insights into early human development but raise complex regulatory and ethical issues globally. Recent recommendations...

AI Boosts Drug Discovery With Open-Source Model for Binding Affinity Prediction

June 10, 2025

Scientists at MIT and Recursion Pharmaceuticals launched Boltz-2, an AI-driven open-source platform that predicts small-molecule binding affinities with improved accuracy. This breakthrough...

CAR-T Therapy Targets Novel Solid Tumor Antigen for Enhanced Immunotherapy

June 10, 2025

Investigators at Nagoya University have engineered a novel CAR-T cell therapy directed against Eva1, a protein overexpressed in various solid tumors including lung, pancreatic, and liver cancers....

Next-Gen Genome Editing Targets Multiple Sites With Precision

June 10, 2025

Researchers are overcoming limitations in human gene editing by developing advanced tools capable of simultaneously modifying multiple genomic sites with enhanced accuracy. This innovation...

Regulatory Shake-Up: Entire CDC Vaccine Advisory Panel Dismissed

June 10, 2025

Health and Human Services Secretary Robert F. Kennedy Jr. removed all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP), citing conflicts of interest and intent to...

Metsera Advances Long-Acting Amylin Analog for Obesity Treatment

June 10, 2025

Metsera has reported encouraging early clinical data for its amylin analog, MET-233i, showing dose-dependent and sustained weight loss with potential for once-monthly dosing. These findings point...

Merck Launches Oral PCSK9 Inhibitor With Positive Phase III Dual Readouts

June 10, 2025

Merck & Co. announced successful Phase III results for its oral PCSK9 inhibitor, enlicitide decanoate, demonstrating significant reductions in LDL cholesterol across two key trials in patients...

Recursion Cuts 20% Workforce Amid Pipeline Narrowing

June 10, 2025

Recursion Pharmaceuticals announced layoffs affecting about 20% of its staff following a strategic pipeline cutback and focus on oncology and rare diseases after merging with Exscientia. The...

Predicting Viral Evolution Reveals Broad SARS-CoV-2 Antibodies

June 10, 2025

A novel computational framework integrating viral evolution modeling and immunology has identified broadly neutralizing antibodies against current and anticipated SARS-CoV-2 variants. This...

Merck’s Oral PCSK9 Inhibitor Clears Hurdle With Phase III Wins

June 10, 2025

Merck announced positive results from two phase III trials of its oral PCSK9 inhibitor, enlicitide decanoate, demonstrating significant reductions in LDL cholesterol in patients on statins with...

Merck’s Oral PCSK9 Inhibitor and Amylin Obesity Drug Poised For Market Impact

June 10, 2025

Merck reported promising Phase III data for its oral PCSK9 inhibitor enlicitide decanoate, showing significant LDL cholesterol reductions, aiming to capture a spot in a competitive market....

Immunotherapy and Electric Fields Combine To Extend Glioblastoma Survival

June 10, 2025

Researchers at Keck Medicine of USC demonstrated that Tumor Treating Fields (TTFields), which use alternating electric fields, combined with immunotherapy and chemotherapy, enhance T-cell...

CUTTING-EDGE COLLAGEN BIOPRINTING TECHNIQUE ADVANCES TISSUE ENGINEERING

June 10, 2025

A biomedical research team at Stony Brook University developed TRACE, a Tunable Rapid Assembly of Collagenous Elements method, enabling instant assembly and 3D bioprinting of physiological...

Revolutionary Rapid AI-Powered Viral Diagnostic Employs Nanopore Technology

June 10, 2025

Researchers unveiled a novel test using solid-state nanopores and machine learning to rapidly detect viral infections by analyzing unique electrical signals as viruses pass through nanoscale...

New Alzheimer’s Blood Test Gains FDA Clearance For Early Detection

June 10, 2025

Indiana University School of Medicine led the development of the first blood test approved by the FDA to detect amyloid plaques in the brain, a hallmark of Alzheimer's disease. The test offers a...

Proteomic Atlas Partnership Targets Alzheimer’s Biomarkers and Dementia Research

June 10, 2025

Alamar Biosciences partnered with the Alzheimer’s Disease Data Initiative and Gates Ventures to create a comprehensive plasma proteome atlas for Alzheimer’s and related dementias. The...

AI Innovations Accelerate Discovery In Complex Disease Genetics and Drug Development

June 10, 2025

Northwestern University researchers developed an AI-driven generative model capable of resolving gene combination patterns underlying complex diseases like diabetes and cancer, surpassing...